ceo holds conference call friday 8a touts possible suitors market reacts, pps goes 250 plus
kerx mentioned in the cowen conference that there is a 8 week extension trial using aux. So if we add that to last week of Jan it will be end of March. Data release could come mid April
they also have interim data mid 2016 for renal cell carcinoma crl101
they were expecting this event to happen early april. Mentioned data comes in May. I expect price to gradually rise to mid 2s before data.
have some $$ set aside for this
i would love that, but maybe a gradual climb to the 12s depending on the overall biotech market next months
last patient was in sometime in january. so I'm thinking next week